Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lujun Chen

Showing results (91-100 of 181) with videos related to

Pageof 19
Sort By:
Oncotargets and Therapy|October 22, 2019
Decreased IFIT2 Expression In Human Non-Small-Cell Lung Cancer Tissues Is Associated With Cancer Progression And Poor Survival Of The PatientsWenya Su, Wenlu Xiao, Lujun Chen, et al.
Acta Histochemica|May 12, 2009
Immunolocalisation of tissue factor in esophageal cancer is correlated with intratumoral angiogenesis and prognosis of the patientLujun Chen, Guanghua Luo, Yan Tan, et al.
Frontiers in Pharmacology|May 4, 2023
Synergistic effect of CD47 blockade in combination with cordycepin treatment against cancerChen Feng, Rongzhang Chen, Weiwei Fang, et al.
International Journal of Clinical and Experimental Pathology|November 18, 2014
Epithelial-to-mesenchymal transition in human esophageal cancer associates with tumor progression and patient's survivalJian Liu, Lujun Chen, Haifeng Deng, et al.
Plos One|March 3, 2018
Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinomaMin Yang, Yuehua Feng, Cuihua Yue, et al.
BMC Cancer|August 7, 2025
Evaluating IL22RA1 expression as a predictive indicator in human colon cancer progressionXuan Yin, Renhao Geng, Junjun Chen, et al.
International Journal of Clinical and Experimental Pathology|July 18, 2014
MT2-MMP expression associates with tumor progression and angiogenesis in human lung cancerLujun Chen, Qi Zhou, Bin Xu, et al.
Cancer Immunology, Immunotherapy : CII|August 6, 2024
Unlocking the potential of HHLA2: identifying functional immune infiltrating cells in the tumor microenvironment and predicting clinical outcomes in laryngeal squamous cell carcinomaWenjing Li, Jianqing You, Haixiang Xue, et al.
Medical Oncology (Northwood, London, England)|August 31, 2023
Single-cell RNA sequencing reveals the effects of anti-PD-L1 therapy on 3LL lung cancer model and its tumor microenvironmentHongyu Zhang, Hao Huang, Shaoxian Wu, et al.
Frontiers in Immunology|April 3, 2026
CX3CR1 identifies a potent effector CD8<sup>+</sup> T cell subset associated with anti-PD-1 therapeutic efficacy in colorectal cancerJiajin Ma, Yue Wu, Rongzhang Chen, et al.
Pageof 19

Showing results (91-100 of 181) with videos related to

Sort By:
Pageof 19
Oncotargets and Therapy|October 22, 2019
Decreased IFIT2 Expression In Human Non-Small-Cell Lung Cancer Tissues Is Associated With Cancer Progression And Poor Survival Of The PatientsWenya Su, Wenlu Xiao, Lujun Chen, et al.
Acta Histochemica|May 12, 2009
Immunolocalisation of tissue factor in esophageal cancer is correlated with intratumoral angiogenesis and prognosis of the patientLujun Chen, Guanghua Luo, Yan Tan, et al.
Frontiers in Pharmacology|May 4, 2023
Synergistic effect of CD47 blockade in combination with cordycepin treatment against cancerChen Feng, Rongzhang Chen, Weiwei Fang, et al.
International Journal of Clinical and Experimental Pathology|November 18, 2014
Epithelial-to-mesenchymal transition in human esophageal cancer associates with tumor progression and patient's survivalJian Liu, Lujun Chen, Haifeng Deng, et al.
Plos One|March 3, 2018
Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinomaMin Yang, Yuehua Feng, Cuihua Yue, et al.
BMC Cancer|August 7, 2025
Evaluating IL22RA1 expression as a predictive indicator in human colon cancer progressionXuan Yin, Renhao Geng, Junjun Chen, et al.
International Journal of Clinical and Experimental Pathology|July 18, 2014
MT2-MMP expression associates with tumor progression and angiogenesis in human lung cancerLujun Chen, Qi Zhou, Bin Xu, et al.
Cancer Immunology, Immunotherapy : CII|August 6, 2024
Unlocking the potential of HHLA2: identifying functional immune infiltrating cells in the tumor microenvironment and predicting clinical outcomes in laryngeal squamous cell carcinomaWenjing Li, Jianqing You, Haixiang Xue, et al.
Medical Oncology (Northwood, London, England)|August 31, 2023
Single-cell RNA sequencing reveals the effects of anti-PD-L1 therapy on 3LL lung cancer model and its tumor microenvironmentHongyu Zhang, Hao Huang, Shaoxian Wu, et al.
Frontiers in Immunology|April 3, 2026
CX3CR1 identifies a potent effector CD8<sup>+</sup> T cell subset associated with anti-PD-1 therapeutic efficacy in colorectal cancerJiajin Ma, Yue Wu, Rongzhang Chen, et al.
Pageof 19